Gambro Renal Care Product Inc Company Profile

11:47 EDT 21st June 2018 | BioPortfolio

HOSPAL was founded in 1977 by the merger of the artificial kidney operations of two European chemical and pharmaceutical companies, Rhône-Poulenc and Sandoz. Both companies had been active in this rapidly developing field for a number of years. In combination, the new organisation gained the now famous high-flux AN69 membrane and the highly valued patented technology for the volumetric control of ultrafiltration.


10810 West Collins Ave
United States of America


Phone: 1/800 525 2623
Fax: 1/303 231 4032

News Articles [1234 Associated News Articles listed on BioPortfolio]

Integrating Kidney Transplantation Into Value-Based Care

The expansion of a comprehensive care model for the care of patients with renal failure will ensure the provision of quality care while reducing costs. American Journal of Transplantation

Older Age, ICU, Poor Renal Fcn Up Risk of Opioid OD in Hospital

TUESDAY, June 12, 2018 -- Risk factors for opioid overdose among hospitalized patients include being age 65 years or older, being in an intensive care unit (ICU), and having renal impairment, accordin...

Caring for renal transplant patients

Renal transplantation improves quantity and quality of life compared with chronic dialysis. A UK general practice with 8000 patients will have around four patients with a functioning renal transplant,...

Gestational Diabetes May Indicate Future Subclinical Renal Issues

THURSDAY, May 10, 2018 -- Gestational diabetes mellitus (GDM) may be an early indicator of subsequent subclinical renal dysfunction, according to a study published online May 4 in Diabetes Care. Shris...

Type 2 Diabetes Ups Risk of Renal Cancer in Women, but Not Men

TUESDAY, May 8, 2018 -- Type 2 diabetes is independently associated with a greater risk of renal cell carcinoma (RCC) in women, but not in men, according to a study published online April 20 in Diabet...

[News] Nivolumab plus ipilimumab in advanced renal-cell carcinoma

The results of the CheckMate 214 study have shown that treatment with nivolumab plus ipilimumab in patients with advanced renal-cell carcinoma can improve outcomes compared with the current standard o...

American Renal Associates Holdings, Inc. Announces Upcoming Conference Appearance

American Renal Associates Holdings, Inc. (NYSE: ARA), a leading provider of dialysis services, today announced it will participate at the Bank of America Merrill Lynch 2018 Health...

Significant advances detected in knowledge about renal cancer

(University of the Basque Country ) The prestigious journal Cell is today publishing three papers on renal cancer signed by an interdisciplinary group known as the TRACERx Renal Consortium, a member o...

Drugs and Medications [36 Associated Drugs and Medications listed on BioPortfolio]

Prismasol [Gambro Renal Products]

PrismaSol Solution

Personal care antibacterial foaming hand wash [Personal Care Products, LLC]

Personal Care Antibacterial Foaming Hand Wash

Personal care [Personal Care Products, Inc.]

Personal Care Medicated Body Powder

Personal care [Personal Care Products, Inc.]

Personal Care Hand Sanitizer Antibacterial with Moisturizers and Vitamin E

Personal care petroleum jelly skin protectant [Personal Care Products, Inc]

Over 75 percent More Free Personal Care Petroleum Jelly Skin Protectant

PubMed Articles [5723 Associated PubMed Articles listed on BioPortfolio]

Renal Replacement Therapy Modality in the ICU and Renal Recovery at Hospital Discharge.

Acute kidney injury requiring renal replacement therapy is a major concern in ICUs. Initial renal replacement therapy modality, continuous renal replacement therapy or intermittent hemodialysis, may i...

Interobserver agreement for post mortem renal histopathology and diagnosis of acute tubular necrosis in critically ill patients.

The renal histopathology of critically ill patients dying with acute kidney injury (AKI) in intensive care units of high income countries remains uncertain.

Hypothesis: early renal replacement therapy increases mortality in critically ill patients with acute on chronic renal failure. A post hoc analysis of the AKIKI trial.

Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system.

Cryptococcosis is the second most common cause of invasive fungal infections in renal transplant recipients in many countries, and data on graft outcome after treatment for this infection is lacking i...

In Cancer Care, Can We Afford To Hope?

At last count, the pharmaceutical industry's new product pipeline included more than 7,000 products in late-stage development, roughly half of which are deemed "specialty." The reality is, our health ...

Clinical Trials [8172 Associated Clinical Trials listed on BioPortfolio]

Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer

The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy

Hypothesis: Free light chain removal haemodialysis will increase the rate of renal recovery in patients with cast nephropathy, severe renal failure and de novo multiple myeloma. This stud...

Developing Of A New Incontinence Care Product

The aim of this randomized controlled clinical trial, prospective study is to developing a new incontinece care product for controlling the fecal and urinary incontinence and to examine th...

In Vivo Sun Protection Factor Determination

The study aims to determine the Sun Protection Factor (SPF) of 8 cosmetic products in vivo on the back of human participants, according to the International Standard Sun Protection Test me...

Lindi Product Satisfaction Survey

This study is being done because the investigators would like to evaluate product satisfaction of three test products (product A, product B, product C) that are available at any drug store...

Companies [3005 Associated Companies listed on BioPortfolio]

Gambro Inc.

Gambro’s business concept is to develop, manufacture, market and provide products and services within the areas of dialysis, intensive care, blood bank technology and therapeutics. Gambro is dedica...

Gambro Renal Care Product Inc

HOSPAL was founded in 1977 by the merger of the artificial kidney operations of two European chemical and pharmaceutical companies, Rhône-Poulenc and Sandoz. Both companies had been active in this ra...

Gambro BCT, Inc

Gambro BCT is an international company with operations in over 50 countries across the globe. Wherever we are, our commitment to building partnerships and better patient outcomes is unwavering

U.S. Renal Care, Inc.

Founded in 2000 by an experienced team of healthcare executives, U.S. Renal Care, Inc. works in partnership with nephrologists to develop, acquire, and operate outpatient treatment centers for persons...

Frenova Renal Research

Frenova is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research. As a Fresenius Medical Care North...

More Information about "Gambro Renal Care Product Inc" on BioPortfolio

We have published hundreds of Gambro Renal Care Product Inc news stories on BioPortfolio along with dozens of Gambro Renal Care Product Inc Clinical Trials and PubMed Articles about Gambro Renal Care Product Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gambro Renal Care Product Inc Companies in our database. You can also find out about relevant Gambro Renal Care Product Inc Drugs and Medications on this site too.

Quick Search


Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record